ACHV
Price
$6.97
Change
-$0.03 (-0.43%)
Updated
Oct 15 closing price
Capitalization
797.49M
21 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$17.03
Change
-$0.00 (-0.00%)
Updated
Sep 23 closing price
Capitalization
884.18M
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs TBPH

ACHV vs TBPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACHV vs. TBPH commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and TBPH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACHV with price predictions
Oct 15, 2026

ACHV in -5.53% downward trend, falling for three consecutive days on October 13, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ACHV declined for three days, in 249 of 304 cases, the price declined further within the following month. The odds of a continued downward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACHV as a result. In 61 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

ACHV moved below its 50-day moving average on October 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACHV crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for ACHV entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHV advanced for three days, in 212 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

ACHV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ACHV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (64.103) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TBPH with price predictions
Oct 15, 2026

TBPH's Stochastic Oscillator is remaining in oversold zone for 13 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on TBPH as a result. In 75 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 96 of 152 cases where TBPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TBPH turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 41 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. TBPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.052) is normal, around the industry mean (26.782). P/E Ratio (16.375) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (8.475) is also within normal values, averaging (437.542).

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
ACHV vs TBPH: Fundamental Ratings
ACHV
TBPH
OUTLOOK RATING
1..100
9048
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
10043
PRICE GROWTH RATING
1..100
3746
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (71) in the Pharmaceuticals Other industry is in the same range as ACHV (81) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ACHV’s over the last 12 months.

TBPH's Profit vs Risk Rating (34) in the Pharmaceuticals Other industry is significantly better than the same rating for ACHV (100) in the Biotechnology industry. This means that TBPH’s stock grew significantly faster than ACHV’s over the last 12 months.

TBPH's SMR Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for ACHV (100) in the Biotechnology industry. This means that TBPH’s stock grew somewhat faster than ACHV’s over the last 12 months.

ACHV's Price Growth Rating (37) in the Biotechnology industry is in the same range as TBPH (46) in the Pharmaceuticals Other industry. This means that ACHV’s stock grew similarly to TBPH’s over the last 12 months.

TBPH's P/E Growth Rating (98) in the Pharmaceuticals Other industry is in the same range as ACHV (100) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVTBPH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
60%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
63%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (ACHV: $6.97 vs. TBPH: $17.03)
Brand notoriety: ACHV and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 70% vs. TBPH: 265%
Market capitalization -- ACHV: $797.49M vs. TBPH: $884.18M
ACHV [@Biotechnology] is valued at $797.49M. TBPH’s [@Biotechnology] market capitalization is $884.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green while TBPH’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 1 green, 4 red.
According to our system of comparison, TBPH is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 3 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 3 bullish, 5 bearish.
  • TBPH’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -3.06% price change this week, while TBPH (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.57%. For the same industry, the average monthly price growth was -12.13%, and the average quarterly price growth was -18.10%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 05, 2026.

TBPH is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-5.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACHV
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNA7.820.14
+1.82%
Atrium Therapeutics Inc.
CSTM25.470.10
+0.39%
Constellium SE
L108.79-0.31
-0.28%
Loews Corp
DQ10.65-0.06
-0.56%
Daqo New Energy Corp
INEO0.54-0.04
-6.67%
INNEOVA Holdings Limited

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with RANI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then RANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-0.43%
RANI - ACHV
42%
Loosely correlated
+1.46%
BEAM - ACHV
36%
Loosely correlated
+4.57%
OGEN - ACHV
35%
Loosely correlated
-0.23%
TBPH - ACHV
33%
Loosely correlated
N/A
CRSP - ACHV
31%
Poorly correlated
+2.59%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ALDX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
N/A
ALDX - TBPH
50%
Loosely correlated
-6.72%
CLDI - TBPH
46%
Loosely correlated
-0.45%
MAZE - TBPH
44%
Loosely correlated
+4.77%
VALN - TBPH
40%
Loosely correlated
+4.42%
SPRC - TBPH
36%
Loosely correlated
-45.65%
More